Dr. Lizarraga is a neuromuscular medicine specialist who focuses on the diagnosis and management of autoimmune neuromuscular disorders, including Myasthenia Gravis (MG), Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and myositis. She completed dual fellowships in both Neuromuscula...

Certified Specialties

Electrodiagnostic Medicine Classification - American Board of Electrodiagnostic Medicine

Faculty Appointments

Associate Professor (Part-Time) - Department of Neurology, NMD (SMD)

Credentials

Residency & Fellowship

Fellowship, Medical Staff, University of Miami Hospital & Clinics. 2015 - 2017

Fellowship, Fellow, University of Miami School of Medicine. 2015 - 2017

Fellowship, Fellow, Brigham & Womens Hospital. 2014 - 2015

Residency, Resident, Jackson Memorial Hospital-Neurology. 2011 - 2014

Internship, Internal Medicine, Jackson Memorial Hospital. 2010 - 2011

Education

MS | University of Miami School of Medicine. 2017

MD | University of Miami School of Medicine. 2010

Publications

Journal Articles

COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections

Jakimovski D, Zakalik K, Awan S, Kavak KS, Pennington P, Hojnacki D, Kolb C, Lizarraga AA, Eckert SP, Sarrosa R, Vineetha K, Edwards K, Weinstock-Guttman B.

Vaccines. 2022; 10(5):695.

Voluntary Cooling during Exercise Is Augmented in People with Multiple Sclerosis Who Experience Heat Sensitivity.

Vargas NT, Chapman CL, Reed EL, Lizarraga A, Fisher NM, Davis SL, Schlader ZJ

Medicine and science in sports and exercise.. 2021 November 153 (11):2405-2418. Epub 1900 01 01.

Peripheral nervous system electrodiagnostic abnormalities in predominantly Hispanic Multiple Sclerosis patients.

Lizarraga AA, Rammohan KW, Weinstock-Guttman B, Sharma K

Multiple sclerosis and related disorders.. 2021 November 56 :103254. Epub 09/04/2021.

Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.

Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ,

Annals of neurology.. 2021 June 89 (6):1088-1098. Epub 02/27/2021.

Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.

Naismith RT, Bermel RA, Coffey CS, Goodman AD, Fedler J, Kearney M, Klawiter EC, Nakamura K, Narayanan S, Goebel C, Yankey J, Klingner E, Fox RJ,

Neurology.. 2021 January 2696 (4):e491-e500. Epub 12/02/2020.

Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.

Hildesheim FE, Ramasamy DP, Bergsland N, Jakimovski D, Dwyer MG, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R

Multiple sclerosis and related disorders.. 2021 January 47 :102653. Epub 12/04/2020.

Late onset multiple sclerosis is associated with more severe ventricle expansion.

Jakimovski D, Dujmic D, Hagemeier J, Ramasamy DP, Bergsland N, Dwyer MG, Eckert S, Kolb C, Lizarraga A, Hojnacki D, Weinstock-Guttman B, Zivadinov R

Multiple sclerosis and related disorders.. 2020 November 46 :102588. Epub 10/17/2020.

Multiple sclerosis in 2019: predicting progression.

Lizarraga AA, Weinstock-Guttman B

The Lancet. Neurology.. 2020 January 19 (1):12-14. Epub 1900 01 01.

Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis.

Genovese AV, Hagemeier J, Bergsland N, Jakimovski D, Dwyer MG, Ramasamy DP, Lizarraga AA, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R

Radiology.. 2019 November 293 (2):424-433. Epub 09/24/2019.

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study.

Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Lizarraga AA, Kolb C, Hojnacki D, Weinstock-Guttman B

Journal of clinical medicine.. 2019 March 128 (3)Epub 03/12/2019.

Medical History and Multiple Sclerosis: A Population-Based Incident Case-Control Study.

Abdollahpour I, Lizarraga AA, Nedjat S, Mansournia MA, Weinstock-Guttman B

Neuroepidemiology.. 2019 52 (1-2):55-62. Epub 11/26/2018.

Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives.

Ozel O, Vaughn CB, Eckert SP, Jakimovski D, Lizarraga AA, Weinstock-Guttman B

Patient related outcome measures.. 2019 10 :373-384. Epub 12/11/2019.

Improvement of distal acquired demyelinating symmetric (DADS) neuropathy after exposure to factor Xa inhibitor.

Lizarraga AA, Cochrane TI, Berkowitz AL

Journal of the neurological sciences.. 2018 May 15388 :146-149. Epub 03/10/2018.

Severe mononeuritis multiplex after rituximab in IgM-? monoclonal gammopathy.

Lizarraga AA, Lizarraga KJ, Hoffman JE, Ascherman DP, Shebert RT, Verma A

Muscle & nerve.. 2018 April 57 (4):E115-E118. Epub 12/01/2017.

Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré Syndrome.

Lizarraga AA, Lizarraga KJ, Benatar M

Seminars in neurology.. 2016 December 36 (6):615-624. Epub 12/01/2016.

Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study.

Economos A, Wright CB, Moon YP, Rundek T, Rabbani L, Paik MC, Sacco RL, Elkind MS

Neuroepidemiology.. 2013 40 (4):253-9. Epub 01/24/2013.

Books

Inflammatory disorders of the nervous system, 2nd Edition (2017)

Chapter: Multiple Sclerosis: clinical features, immunopathogenesis, and clinical management

Pocket Neurology, 2nd Edition (2016)

Chapter: Neuromuscular Junction Disorders

Stroke: Pathophysiology, Diagnosis, and Management, 6th Edition (2015)

Chapter: Vascular dementia and vascular cognitive impairment

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

4.8

Likelihood of recommending this care provider to others

4.9

Explanations the care provider gave you about your problem or condition

4.9

Care provider's efforts to include you in decisions about your care

4.9

Concern the care provider showed for your questions or worries

4.9

Patient Comments

5.0

Dr. Lizarraga was very good and she explained to me the whole process ahead

Dec 27, 2024

5.0

Dr Lizarraga took her time explaining my condition as well as performing a physical exam. [...]

Nov 24, 2024

5.0

I had a very good experience with Dr. Lizarraga, who listened well, answered the questions that I had to the best of her ability, and was thorough and kind.

Nov 05, 2024

5.0

We cannot say enough positives regarding Dr LIZARRAGA. She is a tremendous positive in our lives.

Oct 01, 2024

5.0

This is by far the most heard and cared about than I have felt in years.

Sep 15, 2024

5.0

[...] Very nice, comfortable doctor so I would recommend for other things.

Feb 15, 2024

5.0

Outstanding experience, felt was listened to & supported & happy with my care.

May 23, 2023

5.0

Doctor Lizarraga did the best she could in the short time she had- she would have done better if she had more time

Jan 19, 2023